These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


366 related items for PubMed ID: 16863555

  • 1. Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B.
    Chan HL, Chim AM, Lau JT, Hui AY, Wong VW, Sung JJ.
    Am J Gastroenterol; 2006 Jul; 101(7):1516-23. PubMed ID: 16863555
    [Abstract] [Full Text] [Related]

  • 2. Performance of the new MELD-Na score in predicting 3-month and 1-year mortality in Chinese patients with chronic hepatitis B.
    Wong VW, Chim AM, Wong GL, Sung JJ, Chan HL.
    Liver Transpl; 2007 Sep; 13(9):1228-35. PubMed ID: 17763399
    [Abstract] [Full Text] [Related]

  • 3. Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.
    Dai CY, Chuang WL, Hou NJ, Lee LP, Hsieh MY, Lin ZY, Chen SC, Huang JF, Hsieh MY, Wang LY, Tsai JF, Wen-Yu, Yu ML.
    Clin Ther; 2006 Dec; 28(12):2081-92. PubMed ID: 17296464
    [Abstract] [Full Text] [Related]

  • 4. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure.
    Wang ZX, Yan LN, Wang WT, Xu MQ, Yang JY.
    Transplant Proc; 2007 Jun; 39(5):1501-4. PubMed ID: 17580172
    [Abstract] [Full Text] [Related]

  • 5. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH, Liu HB, Wang Y, Wang BY, Song M, Sun MJ.
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [Abstract] [Full Text] [Related]

  • 6. [Analysis of short-term prognosis on patients with chronic severe hepatitis B using the model for end-stage liver disease].
    Zhou J, He WF, Tang XE.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):416-8. PubMed ID: 17631710
    [Abstract] [Full Text] [Related]

  • 7. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model.
    Sun QF, Ding JG, Xu DZ, Chen YP, Hong L, Ye ZY, Zheng MH, Fu RQ, Wu JG, Du QW, Chen W, Wang XF, Sheng JF.
    J Viral Hepat; 2009 Jul; 16(7):464-70. PubMed ID: 19413694
    [Abstract] [Full Text] [Related]

  • 8. Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B.
    Cai CJ, Chen HA, Lu MQ, Chen GH.
    Chin Med J (Engl); 2008 Oct 20; 121(20):2065-9. PubMed ID: 19080277
    [Abstract] [Full Text] [Related]

  • 9. Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment.
    Yu JW, Sun LJ, Zhao YH, Li SC.
    J Gastroenterol Hepatol; 2008 Aug 20; 23(8 Pt 1):1242-9. PubMed ID: 18637053
    [Abstract] [Full Text] [Related]

  • 10. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.
    Huo TI, Lin HC, Wu JC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD.
    Liver Transpl; 2006 Jan 20; 12(1):65-71. PubMed ID: 16382473
    [Abstract] [Full Text] [Related]

  • 11. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW, Huo TI, Yang YY, Hou MC, Lee PC, Lin HC, Lee FY, Chi CW, Lee SD.
    J Clin Gastroenterol; 2007 Aug 20; 41(7):706-12. PubMed ID: 17667056
    [Abstract] [Full Text] [Related]

  • 12. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
    Giannini E, Botta F, Testa E, Romagnoli P, Polegato S, Malfatti F, Fumagalli A, Chiarbonello B, Risso D, Testa R.
    Am J Gastroenterol; 2002 Nov 20; 97(11):2855-60. PubMed ID: 12425560
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD.
    J Hepatol; 2005 Jun 20; 42(6):826-32. PubMed ID: 15885353
    [Abstract] [Full Text] [Related]

  • 14. [Clinical value of Child-Turcotte-Pugh and model for end-stage liver disease score to predict the prognosis of chronic severe hepatitis].
    Jiang ZS, Jiang JN.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul 20; 19(7):412-5. PubMed ID: 17631709
    [Abstract] [Full Text] [Related]

  • 15. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI, Lin HC, Hsia CY, Huang YH, Wu JC, Chiang JH, Chiou YY, Lui WY, Lee PC, Lee SD.
    Dig Liver Dis; 2008 Nov 20; 40(11):882-9. PubMed ID: 18339595
    [Abstract] [Full Text] [Related]

  • 16. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month].
    Bae WK, Lee JS, Kim NH, Kim KA, Moon YS, Oh MK.
    Korean J Hepatol; 2007 Mar 20; 13(1):51-60. PubMed ID: 17380075
    [Abstract] [Full Text] [Related]

  • 17. Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation.
    Dai CY, Yu ML, Hsieh MY, Lee LP, Hou NJ, Huang JF, Chen SC, Lin ZY, Hsieh MY, Wang LY, Tsai JF, Chang WY, Chuang WL.
    Liver Int; 2007 Dec 20; 27(10):1364-70. PubMed ID: 17900250
    [Abstract] [Full Text] [Related]

  • 18. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
    Radha Krishna Y, Saraswat VA, Das K, Himanshu G, Yachha SK, Aggarwal R, Choudhuri G.
    Liver Int; 2009 Mar 20; 29(3):392-8. PubMed ID: 19267864
    [Abstract] [Full Text] [Related]

  • 19. The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy.
    Huo TI, Lin HC, Huang YH, Wu JC, Chiang JH, Lee PC, Lee SD.
    Cancer; 2006 Jul 01; 107(1):141-8. PubMed ID: 16708358
    [Abstract] [Full Text] [Related]

  • 20. MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis.
    Srikureja W, Kyulo NL, Runyon BA, Hu KQ.
    J Hepatol; 2005 May 01; 42(5):700-6. PubMed ID: 15826720
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.